
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 22-Nov-2022 titled Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for Axitinib Tablets, 1 mg and 5 mg
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 22-Nov-2022 titled Glenmark Pharmaceuticals reaches settlement agreement with Pfizer for Axitinib Tablets, 1 mg and 5 mg
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals